HomeNKB2 • FRA
add
TG Therapeutics Inc common stock
Nakaraang pagsara
€29.80
Sakop ng araw
€29.69 - €29.69
Sakop ng taon
€12.08 - €34.17
Market cap
4.86B USD
Average na Volume
170.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 83.88M | -49.41% |
Gastos sa pagpapatakbo | 62.10M | 30.68% |
Net na kita | 3.88M | -96.59% |
Net profit margin | 4.63 | -93.26% |
Kita sa bawat share | 0.02 | -97.26% |
EBITDA | 12.44M | -89.16% |
Aktuwal na % ng binabayarang buwis | 9.09% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 341.04M | 48.82% |
Kabuuang asset | 586.01M | 77.01% |
Kabuuang sagutin | 393.86M | 136.84% |
Kabuuang equity | 192.16M | — |
Natitirang share | 143.52M | — |
Presyo para makapag-book | 22.24 | — |
Return on assets | 6.30% | — |
Return on capital | 8.44% | — |
Cash Flow
Net change in cash
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 3.88M | -96.59% |
Cash mula sa mga operasyon | -12.20M | -114.58% |
Cash mula sa pag-invest | -9.33M | 69.12% |
Cash mula sa financing | 134.45M | 31,836.82% |
Net change in cash | 112.92M | 109.51% |
Malayang cash flow | -31.00M | -181.67% |
Tungkol
Itinatag
1993
Headquarters
Website
Mga Empleyado
319